Celgene (NASDAQ:CELG) Shares Sold by Shepherd Financial Partners LLC

Alicia Farmer
April 21, 2018

Celgene announced that its Board of Directors has approved a share buyback program on Wednesday, February 14th that permits the company to buyback $5.00 billion in shares. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 21, 2017 and is downtrending. CELG underperformed the S&P500 by 42.83%.

In Celgene Corp (CELG) was decreased the stake owned by Clarivest Asset Management Llc. Linscomb & Williams Inc. now owns 3,813 shares of the biopharmaceutical company's stock worth $495,000 after buying an additional 36 shares during the last quarter. 3,543 are owned by Budros Ruhlin And Roe Inc. The stock decreased 1.45% or $0.95 during the last trading session, reaching $64.73. The stock was sold at an average price of $94.83, for a total transaction of $877,177.50. It also reduced its holding in Mohawk Inds Inc (NYSE:MHK) by 165,000 shares in the quarter, leaving it with 250,000 shares, and cut its stake in Facebook Inc (NASDAQ:FB). (NASDAQ:TROW) stake by 9,569 shares to 74,807 valued at $7.85 million in 2017Q4. It also increased its holding in Paycom Software Inc (NYSE:PAYC) by 150,000 shares in the quarter, for a total of 2.14M shares, and has risen its stake in Grupo Televisa Sab Cpo Adr (NYSE:TV). Spdr Ser Tr was raised too. On Wednesday, February 28 Credit Suisse maintained Celgene Corporation (NASDAQ:CELG) rating. Therefore 50% are positive. ICHOR Corporation had 4 analyst reports since January 11, 2017 according to SRatingsIntel. The stock has "Overweight" rating by JP Morgan on Thursday, October 1. (NASDAQ:ENT) earned "Buy" rating by Northland Capital on Monday, August 28. The rating was maintained by Morgan Stanley with "Underweight" on Monday, October 23. The company was maintained on Sunday, April 15 by Piper Jaffray. (NASDAQ:AMGN) on Monday, June 12 with "Hold" rating. As per Friday, February 10, the company rating was maintained by Needham. Bernstein downgraded the shares of CELG in report on Wednesday, December 27 to "Market Perform" rating. The stock of Western Alliance Bancorporation (NYSE:WAL) has "Buy" rating given on Friday, July 21 by RBC Capital Markets. The rating was maintained by Dougherty & Company on Monday, January 9 with "Buy". SunTrust maintained the stock with "Buy" rating in Friday, October 27 report.

Investors sentiment decreased to 0.8 in Q4 2017. Its up 2.19, from 1.55 in 2017Q3. (NASDAQ:AMGN) for 230,915 shares. Arcadia Investment Management Corp MI now owns 737 shares of the biopharmaceutical company's stock worth $107,000 after buying an additional 400 shares during the last quarter. Moreover, Advisory Rech has 0.02% invested in Care.com, Inc. Supplemental Annuity Collective Tru Of Nj holds 0.66% or 9,000 shares in its portfolio. Hartwell J M Ltd Partnership invested in 0.14% or 7,350 shares. The Colorado-based Icon Advisers Inc Co has invested 0.02% in the stock. Jennison Associates Ltd accumulated 1.01% or 9.82 million shares. Security Fincl Bank Of So Dak reported 1.44% in AbbVie Inc. Granite Inv Partners Lc invested 0.04% of its capital in Celgene Corporation (NASDAQ:CELG). Sphera Funds Management Ltd who had been investing in Celgene Corp for a number of months, seems to be bullish on the $66.91B market cap company. 247,607 were reported by Gulf Bancshares (Uk) Limited. Raymond James initiated the shares of CELG in report on Tuesday, September 1 with "Strong-Buy" rating. Lazard Asset Mngmt Ltd Co stated it has 0.03% in Amgen Inc. Nokota Management Lp has invested 0.12% in Wells Fargo & Company (NYSE:WFC).

Analysts await Amgen Inc. The firm has a market cap of $67,409.98, a P/E ratio of 13.06, a price-to-earnings-growth ratio of 0.60 and a beta of 1.49. The institutional investor held 309,000 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $32.25 million, up from 275,000 at the end of the previous reported quarter.

General Motors Company (GM) stock dipped -11.58% Quarterly performance
Following the transaction, the chief financial officer now owns 26,052 shares of the company's stock, valued at $1,065,005.76. Atalanta Sosnoff Capital Limited Liability Corporation holds 0.02% in General Motors Company (NYSE:GM) or 12,500 shares.

Becker Capital Management INC Decreased Its Stake in Walmart INC (WMT)
MATSCHULLAT ROBERT W sold $707,561 worth of Visa Inc. (NYSE:WMT). 577,000 are owned by Stewart West Indies Trading Limited. The stock of AbbVie Inc. (NYSE:V) has "Buy" rating given on Wednesday, December 13 by KeyBanc Capital Markets.

Anticipated $1.59 EPS for Gilead Sciences, Inc. (GILD) as of May, 1
Stonebridge Capital Management Inc increased Gilead Sciences Inc Com (GILD) stake by 28.42% reported in 2017Q4 SEC filing. During the same period previous year , the firm earned $2.70 earnings per share. (NASDAQ:GILD) on Thursday, March 1.

Since December 12, 2017, it had 0 insider buys, and 5 selling transactions for $1.37 million activity. $119,351 worth of stock was sold by Michael Robert A. on Monday, February 19. KAPLAN GILLA sold $1.77 million worth of stock or 18,500 shares. 3,260 shares valued at $299,594 were bought by Alles Mark J on Thursday, February 8. Shares for $1.26 million were sold by MARIO ERNEST. Therefore 54% are positive. 49 are the (NASDAQ:CELG)'s ratings reports on April 21, 2018 according to StockzIntelligence Inc. On Wednesday, April 4 the rating was maintained by RBC Capital Markets with "Buy". Benchmark has "Buy" rating and $115000 target. Cantor Fitzgerald maintained the stock with "Buy" rating in Tuesday, September 26 report. SunTrust Banks reiterated a "buy" rating and issued a $139.00 target price (up from $127.00) on shares of Celgene in a research report on Friday, January 26th. Analysts have placed a $115.62 price target on Celgene Corporation, suggesting a 29.01% gain from recent close. Canaccord Genuity has "Buy" rating and $1250 target.

During Q4 2017 the big money sentiment decreased to 0.83. Its down 0.06, from 1.32 in 2017Q3. 156 investors sold all, 478 reduced holdings as Celgene Corporation ratio turned negative. 118 funds opened positions while 411 raised stakes. Investors holded 603.99 million in 2017Q3 but now own 561.38 million shares or 7.06% less. First Commonwealth Corp Pa has invested 0.74% in Celgene Corporation (NASDAQ:CELG). Smith Moore And Comm holds 2,478 shares or 0.07% of its portfolio. State Of New Jersey Common Pension Fund D accumulated 500,000 shares or 0.2% of the stock. Los Angeles Capital Mgmt Equity Research has invested 0.01% in Care.com, Inc. 4,500 are owned by Fukoku Mutual Life Com. Dana Advisors Inc has 46,850 shares for 0.21% of their portfolio. Associated Banc stated it has 120,369 shares. Greystone Managed Investments Incorporated holds 0.25% or 57,732 shares. Massachusetts-based Bainco Intll Invsts has invested 0.86% in Celgene Corporation (NASDAQ:CELG). About 5.28M shares traded. Invesco invested 0% of its portfolio in Care.com, Inc. Hugh Johnson Ltd holds 0.66% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 21,500 shares. Clear Harbor Asset Mgmt Limited Liability invested in 0.07% or 3,326 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER